Table 3.
SARS-CoV-2 Assay | Positive (n = 144) |
Negative (n = 227) | Sensitivity (95% CI) |
Accuracy |
---|---|---|---|---|
SORP Triplex | 143 | 0 | 99.31% (96.19–99.98) |
99.73% (98.51–99.99) |
US-CDC N1/N2 | 142* | 0 | 99.30% (96.17–99.98) |
99.73% (98.51–99.99) |
SARS-CoV-2 Assay | Positive (n = 144) |
Negative (n = 227) | Sensitivity (95% CI) |
Accuracy |
---|---|---|---|---|
SORP Triplex | 143 | 0 | 99.31% (96.19–99.98) |
99.73% (98.51–99.99) |
US-CDC N1/N2 | 142* | 0 | 99.30% (96.17–99.98) |
99.73% (98.51–99.99) |